Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary vascular abnormalities in cirrhosis.
Herve P, Le Pavec J, Sztrymf B, Decante B, Savale L, Sitbon O. Herve P, et al. Among authors: savale l. Best Pract Res Clin Gastroenterol. 2007;21(1):141-59. doi: 10.1016/j.bpg.2006.07.011. Best Pract Res Clin Gastroenterol. 2007. PMID: 17223502 Review.
Portopulmonary hypertension: survival and prognostic factors.
Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jaïs X, Yaïci A, Humbert M, Simonneau G, Sitbon O. Le Pavec J, et al. Among authors: savale l. Am J Respir Crit Care Med. 2008 Sep 15;178(6):637-43. doi: 10.1164/rccm.200804-613OC. Epub 2008 Jul 10. Am J Respir Crit Care Med. 2008. PMID: 18617641
[Pulmonary arterial hypertension].
Jaïs X, Sitbon O, Savale L, Montani D, Humbert M, Simonneau G. Jaïs X, et al. Among authors: savale l. Rev Prat. 2008 Nov 30;58(18):1997-2010. Rev Prat. 2008. PMID: 19143271 Free article. Review. French.
Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D, Chaumais MC, Savale L, Natali D, Price LC, Jaïs X, Humbert M, Simonneau G, Sitbon O. Montani D, et al. Among authors: savale l. Adv Ther. 2009 Sep;26(9):813-25. doi: 10.1007/s12325-009-0064-z. Epub 2009 Sep 19. Adv Ther. 2009. PMID: 19768639 Review.
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M. Launay D, et al. Among authors: savale l. Rheumatology (Oxford). 2010 Mar;49(3):490-500. doi: 10.1093/rheumatology/kep398. Epub 2009 Dec 16. Rheumatology (Oxford). 2010. PMID: 20015974 Clinical Trial.
280 results